Bolt Biotherapeutics, Inc. appointed Nathan Ihle, Ph.D., as vice president of chemistry, manufacturing and controls (CMC) and quality. He will oversee and manage Bolt's manufacturing, process and analytical development, and CMC regulatory strategies. He brings 18 years of CMC strategy and management experience to Bolt.